Replimune Group Inc (NASDAQ:REPL), a biotechnology company specializing in oncolytic immunotherapy for cancer treatment with a current market capitalization of $803 million, has been making ...
Hilltop Holdings Inc . (NYSE:HTH), a Texas-based financial holding company with a market capitalization of $1.86 billion, has ...